Maximum treatment capacity with a multiple-use adsorber
As with all extracorporeal methods, the patient's blood is first removed from their arm or a large vein. The next step is to separate the blood into its cellular components and plasma, either by filtration or centrifugation.
The plasma is then passed through the selective or semi-selective adsorber for the desired binding of immunglobulines.
For many autoimmune diseases, it is necessary to remove as many antibodies as possible, as quickly as possible.
Fresenius Medical Care offers sophisticated systems that use different immunoadsorber types to meet the patient’s individual needs. For instance, the application of multiple-use adsorbers (GLOBAFFIN) facilitates a very potent therapy that consistently eliminates a high proportion of immunoglobulins, thanks to a built-in regeneration process.